BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 12478285)

  • 1. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin.
    Groppe J; Greenwald J; Wiater E; Rodriguez-Leon J; Economides AN; Kwiatkowski W; Affolter M; Vale WW; Izpisua Belmonte JC; Choe S
    Nature; 2002 Dec; 420(6916):636-42. PubMed ID: 12478285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein.
    Groppe J; Greenwald J; Wiater E; Rodriguez-Leon J; Economides AN; Kwiatkowski W; Baban K; Affolter M; Vale WW; Izpisua Belmonte JC; Choe S
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():52-8. PubMed ID: 12925610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.
    Ahmed S; Metpally RP; Sangadala S; Reddy BV
    J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated expression of noggin and bone morphogenetic proteins (BMPs) during early skeletogenesis and induction of noggin expression by BMP-7.
    Nifuji A; Noda M
    J Bone Miner Res; 1999 Dec; 14(12):2057-66. PubMed ID: 10620065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricting Bmp-4 mediated apoptosis in hindbrain neural crest.
    Smith A; Graham A
    Dev Dyn; 2001 Mar; 220(3):276-83. PubMed ID: 11241835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphogenesis of digits in the avian limb is controlled by FGFs, TGFbetas, and noggin through BMP signaling.
    Merino R; Gañan Y; Macias D; Economides AN; Sampath KT; Hurle JM
    Dev Biol; 1998 Aug; 200(1):35-45. PubMed ID: 9698454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular recognition of BMP-2 and BMP receptor IA.
    Keller S; Nickel J; Zhang JL; Sebald W; Mueller TD
    Nat Struct Mol Biol; 2004 May; 11(5):481-8. PubMed ID: 15064755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the BMP-2-BRIA ectodomain complex.
    Kirsch T; Sebald W; Dreyer MK
    Nat Struct Biol; 2000 Jun; 7(6):492-6. PubMed ID: 10881198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural biology: On the wings of inhibition.
    Wrana JL
    Nature; 2002 Dec; 420(6916):613-4. PubMed ID: 12478270
    [No Abstract]   [Full Text] [Related]  

  • 10. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
    Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
    J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.
    Weber FE; Schmökel H; Oelgeschläger M; Nickel J; Maly FE; Hortschansky P; Grätz KW
    J Bone Miner Res; 2003 Dec; 18(12):2142-51. PubMed ID: 14672349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental expression patterns of bone morphogenetic proteins, receptors, and binding proteins in the chick retina.
    Belecky-Adams T; Adler R
    J Comp Neurol; 2001 Feb; 430(4):562-72. PubMed ID: 11169487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.
    Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T
    Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.
    Kirsch T; Nickel J; Sebald W
    EMBO J; 2000 Jul; 19(13):3314-24. PubMed ID: 10880444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
    Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
    BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
    Sebald W; Nickel J; Zhang JL; Mueller TD
    Biol Chem; 2004 Aug; 385(8):697-710. PubMed ID: 15449706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural crest cell migration of mouse B16-F1 melanoma cells transplanted into the chick embryo is inhibited by the BMP-antagonist noggin.
    Busch C; Drews U; Garbe C; Eisele SR; Oppitz M
    Int J Oncol; 2007 Dec; 31(6):1367-78. PubMed ID: 17982664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists.
    Avsian-Kretchmer O; Hsueh AJ
    Mol Endocrinol; 2004 Jan; 18(1):1-12. PubMed ID: 14525956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.